Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc T.NUMI

Alternate Symbol(s):  NUMIF

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Recent & Breaking News (TSX:NUMI)

Numinus to Host Q2 2023 Results Conference Call on April 13, 2023

PR Newswire March 30, 2023

Numinus Launches the Practitioner Certification Pathway - a Complete Psychedelic-Assisted Therapy Training Program

PR Newswire March 27, 2023

Numinus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

PR Newswire March 22, 2023

Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023

PR Newswire March 21, 2023

Numinus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest Conference

PR Newswire March 7, 2023

Numinus to Participate in a Water Tower Research Fireside Chat on Tuesday, February 28, 2023

PR Newswire February 24, 2023

Numinus Expands Research Capabilities with new Phoenix Clinical Research Site

PR Newswire February 17, 2023

Numinus Wellness Announces Voting Results From its Annual General and Special Meeting of Shareholders

PR Newswire February 15, 2023

Numinus (TSX:NUMI) receives Health Canada approval for psychedelic tea therapy

Caroline Egan  February 1, 2023

Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea

PR Newswire February 1, 2023

Numinus Wellness Inc. Reports Q1 2023 Results

PR Newswire January 16, 2023

Numinus to Host Q1 2023 Results Conference Call on January 16, 2023

PR Newswire January 4, 2023

Proactive research analyst on Numinus Wellness' annual results

TheNewsWire December 19, 2022

Numinus to Participate in the KCSA Mental Health Virtual Investor Conference on December 15, 2022

PR Newswire December 12, 2022

Numinus Submits Clinical Trial Application to Health Canada for Experiential Psilocybin-Assisted Therapy Training Research

PR Newswire December 8, 2022

Numinus Q4 results reflect strength of the Novamind acquisition

Research December 5, 2022

IIROC Trade Resumption - NUMI

Canada NewsWire November 30, 2022

IIROC Trading Halt - NUMI

Canada NewsWire November 29, 2022

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

PR Newswire November 29, 2022

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022

PR Newswire November 22, 2022